Mather Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5K Buy
+64
New +$1.16K ﹤0.01% 1732
2025
Q4
Sell
-116
Closed -$2.87K 650
2025
Q3
$2.87K Buy
+116
New +$2.59K ﹤0.01% 1491
2025
Q2
Sell
-390
Closed -$11.8K 621
2025
Q1
$11.8K Sell
390
-189
-33% -$7.2K ﹤0.01% 1206
2024
Q4
$23K Buy
579
+12
+2% +$541 ﹤0.01% 1052
2024
Q3
$36K Sell
567
-60
-10% -$4.33K ﹤0.01% 945
2024
Q2
$49.7K Buy
627
+4
+0.6% +$279 ﹤0.01% 1000
2024
Q1
$48.4K Buy
+623
New +$50.9K ﹤0.01% 881

Other funds holding ACHC

Mather Group's ACHC Position: Q1 2026 in Review

Mather Group opened a new position in Acadia Healthcare (ACHC) in Q1 2026: 64 shares worth $1.5K. The stake represents ﹤0.01% of the portfolio and ranks #1732 among its holdings. This is a return to the name: Mather Group previously reported a position in ACHC as recently as Q3 2025.

Mather Group first reported a position in ACHC in Q1 2024 and has held it in 7 quarters since. The position peaked at $49.7K in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Mather Group held 64 shares of Acadia Healthcare worth $1.5K as of Q1 2026.
  • Acadia Healthcare was a new Mather Group position in Q1 2026.
  • Acadia Healthcare made up ﹤0.01% of Mather Group's portfolio in Q1 2026, its #1732 holding.
  • Mather Group first reported a position in Acadia Healthcare in Q1 2024 and has held it in 7 quarters since.
  • Mather Group's Acadia Healthcare position peaked at $49.7K in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.